MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001104/mwtabprimaryOK200MetabolomicsMass SpectrometryESITuberculosisHomo Sapienshttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001104Sample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidase and O-glycosidase for comparison with seryl-leucine standardSample Type:Patient urineSample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidase and O-glycosidaseSample Type:Enriched SLC1G after treatment with a2-3 neuraminidaseSample Type:Seryl-leucine StandardSample Type:Enriched SLC1GSample Type:Enriched SLC1G after treatment with a2-3,6,8 neuraminidaseColorado State UniversityUrineReversed phase POSITIVE ION MODE/TOF. Reversed phase POSITIVE ION MODE/QTOF.MetabolomicsWorkbenchGalactose-N-acetylgalactosamine-SLSLC1GSer-LeuGalactose-N-acetylgalactosamineN-acetylneuraminic acidL-Leucine, polypeptide, peptide, (RS)-Leucine, Polypeptides, L-Isomer Leucine, peptido, peptides, Leucine, L, DL-Leucine, 2-amino-4-methylpentanoic acid, core, L Isomer, Peptid, peptidos, Leuzin, Polypeptide, Hleu, L-Isomer, (+-)-Leucine, Leucin, Peptide., LeuFEZL, VSD1, ZFP312, backward, reversed., TOF, FEZ, TACHD, ZNF312, reversed, ASD2falseSeryl-leucine core 1 O-glycosylated peptide (SLC1G) identificationST0011049606